INTERLEUKIN-6 IN THE EPIDERMIS OF PATIENTS WITH PSORIASIS BEFORE AND DURING PUVA TREATMENT

被引：0
|
作者：
OXHOLM, A
OXHOLM, P
STABERG, B
BENDTZEN, K
机构：
[1] UNIV COPENHAGEN,RIGSHOSP,MED IMMUNOL LAB,DK-2100 COPENHAGEN O,DENMARK
[2] KOMMUNE HOSP,INST PATHOL ANAT,DK-1399 COPENHAGEN,DENMARK
来源：
ACTA DERMATO-VENEREOLOGICA | 1989年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：195 / 199
页数：5
相关论文
共 50 条
  • [31] SERUM LEVELS OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA IN HYPERTHYROID PATIENTS BEFORE AND AFTER PROPYLTHIOURACIL TREATMENT
    CELIK, I
    AKALIN, S
    ERBAS, T
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (06) : 668 - 672
  • [32] USE OF INTERLEUKIN-6 INHIBITOR IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN ELDERLY PATIENTS
    Shilova, L.
    Spitsina, S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S292 - S293
  • [33] Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus
    S. Kado
    T. Nagase
    N. Nagata
    Acta Diabetologica, 1999, 36 : 67 - 72
  • [34] Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus
    Kado, S
    Nagase, T
    Nagata, N
    ACTA DIABETOLOGICA, 1999, 36 (1-2) : 67 - 72
  • [35] Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
    Pecoits-Filho, R
    Bárány, P
    Lindholm, B
    Heimbürger, O
    Stenvinkel, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (09) : 1684 - 1688
  • [36] Serum interleukin-6 levels in response to methotrexate treatment in psoriatic patients
    Elango, Tamilselvi
    Dayalan, Haripriya
    Subramanian, Swapna
    Gnanaraj, Pushpa
    Malligarjunan, Hemamalini
    CLINICA CHIMICA ACTA, 2012, 413 (19-20) : 1652 - 1656
  • [37] INDUCTION OF INTERLEUKIN-6 IN THE EPIDERMIS OF MICE IN RESPONSE TO TUMOR-PROMOTING AGENTS
    VASUNIA, KB
    MILLER, ML
    ANDRINGA, S
    BAXTER, CS
    CARCINOGENESIS, 1994, 15 (08) : 1723 - 1727
  • [38] Is there any relationship between interleukin-6/interleukin-6 receptor modulation and endogenous interleukin-6 release in metastatic malignant melanoma patients treated by biochemotherapy?
    Mouawad, R
    Khayat, D
    Merle, S
    Antoine, EC
    Gil-Delgado, M
    Soubrane, C
    MELANOMA RESEARCH, 1999, 9 (02) : 181 - 188
  • [39] Integrating Interleukin-6 into depression diagnosis and treatment
    Hodes, Georgia E.
    Menard, Caroline
    Russo, Scott J.
    NEUROBIOLOGY OF STRESS, 2016, 4 : 15 - 22
  • [40] INTERLEUKIN-6 AS A POTENTIAL TARGET FOR OA TREATMENT
    Eitner, Annett
    Koenig, Christian
    Kohler, Felix C.
    Hofmann, Gunther
    Wildemann, Britt
    Aurich, Matthias
    Schaible, Hans-Georg
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S433 - S433
12345